The DOI matches its Crossref record.
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Abstract
The subunit composition and pharmacological regulation of rat neuronal nicotinic cholinergic receptors were assessed. Specific immunoprecipitation was determined in solubilized rat brain homogenates using [3H]cytisine, a high affinity agonist at nicotinic receptors, in conjunction with polyclonal antisera generated against nonhomologous domains of the various subunits comprising this receptor class. In all brain regions tested, only antisera generated against the alpha 4 and beta 2 subunits were able to immunoprecipitate specifically receptors labeled by [3H]cytisine. Thus, these sera were further characterized in order to validate and optimize their use in the immunoprecipitation protocol. Preincubation of solubilized receptors from rat forebrain with antisera generated against the alpha 2, alpha 3, alpha 5, beta 3, or beta 4 subunits did not decrease the amount of precipitable alpha 4 or beta 2 subunit. On the other hand, when either anti-alpha 4 or anti-beta 2 serum was used to immunoprecipitate solubilized receptors from rat forebrain, the supernatants contained little if any remaining receptors that could be specifically precipitated by either antibody. Because these antisera do not cross-react, the data indicate that alpha 4 and beta 2 subunits are associated with each other in at least one neuronal nicotinic receptor subtype that has high affinity for agonists. Moreover, these results imply that all alpha 4 subunits that are labeled by [3H]cystisine are coupled to beta 2 subunits. We also present evidence that the alpha 4/beta 2 subtype characterized in this report is significantly increased in the cortex of rats chronically treated with nicotine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, nicotine induced increases in nAChR, termed “upregulation”, are conferred by a specific microdomain that is in the β2-subunit 34 and thus this upregulation is confined to nAChR that contain the β2-subunit4, 19, 31, 35-38.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [19]
In the citing paper
“Immunoprecipitation with subunit-selective antibodies and studies in genetic knockout models demonstrate that chronic administration of nicotine increases predominantly the ␣42 subtype of nAChRs in rodent brain (Flores et al., 1992;Mao et al., 2008;Moretti et al., 2010;Marks et al., 2011)”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Flores et al., 1992
Citations
Cited by
Sorted by citations
Items 301–400 of 880
Xie, P., Kranzler, H. R., Krauthammer, M. O., Cosgrove, K., Oslin, D. W., Anton, R. F., Farrer, L. A., Picciotto, M. R., Krystal, J. H., Zhao, H., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.017 · Cited by 62
Lower β2*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia
D’Souza, D. C., Esterlis, I., Carbuto, M., Krasenics, M., Seibyl, J. P., Bois, F., Pittman, B. P., Ranganathan, M., Cosgrove, K., & Staley, J. K. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020189 · Cited by 62
Mennenga, S. E., Gerson, J. E., Koebele, S. V., Kingston, M. L., Tsang, C. W. S., Engler-Chiurazzi, E. B., Baxter, L. C., & Bimonte‐Nelson, H. A. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.01.002 · Cited by 69
Tournier, J., Maouche, K., Coraux, C., Zahm, J., Cloëz-Tayarani, I., Nawrocki‐Raby, B., Bonnomet, A., Burlet, H., Lebargy, F., Polette, M., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050333 · Cited by 61
Mousavi, M. T., Hellström‐Lindahl, E., Guan, Z.-Z., Shan, K.-R., Ravid, R., & Nordberg, A. K. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00460-3 · Cited by 61
Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types
Martin-Ruiz, C. M., COURT, J. A., Lee, M., Piggott, M. A., Johnson, M. A., Ballard, C. G., Kalaria, R. N., Perry, R., & Perry, E. K. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00305.x · Cited by 61
Sullivan, J. P., & Bannon, A. W. (1996) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1996.tb00288.x · Cited by 60
Serotonin receptors as potential targets for modulation of nicotine use and dependence
Fletcher, P. J., LE, A., & Higgins, G. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00918-7 · Cited by 61
Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors
Ficklin, M. B., Zhao, S., & Feng, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506781200 · Cited by 59
The effect of prenatal nicotine on expression of nicotine receptor subunits in the fetal brain.
Lv, J., Mao, C., Zhu, L.-Y., Zhang, H., Hui, P., Xu, F.-C., Liu, Y.-J., Zhang, L.-B., & Xu, Z.-C. (2008) · Neurotoxicology · doi:10.1016/j.neuro.2008.04.015 · Cited by 58
Curzon, P., Nikkel, A. L., Bannon, A. W., Arnerić, S. P., & Decker, M. W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37871-1 · Cited by 59
Kassiou, M., Eberl, S., Meikle, S. R., Birrell, A., Constable, C., Fulham, M. J., Wong, D. F., & Musachio, J. L. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00206-7 · Cited by 58
Role of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 59
Sihver, W., Gillberg, P., & Nordberg, A. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00652-0 · Cited by 57
Jeune, H. L., Aubert, I., Jourdan, F., & Quirion, R. (1995) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(95)00070-n · Cited by 58
Meyer, E. L., Xiao, Y., & Kellar, K. J. (2001) · PubMed · Cited by 58
The effect of nicotine on developing brain catecholamine systems
Heather, S. (1999) · Frontiers in bioscience · doi:10.2741/oliff · Cited by 67
Ridley, D. L., Rogers, A. T., & Wonnacott, S. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704207 · Cited by 58
Galindo‐Charles, L., Hernández‐López, S., Galarraga, E., Tapia, D., Bargas, J., Garduño, J., Frías‐Dominguez, C., Drucker-Colı́n, R., & Mihailescu, S. (2008) · Synapse · doi:10.1002/syn.20526 · Cited by 58
Nicotinic receptor modulation to treat alcohol and drug dependence
Rahman, S., Engleman, E. A., & Bell, R. L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00426 · Cited by 60
Ellis, J. R., Villemagne, V. L., Nathan, P. J., Mulligan, R. S., Gong, S., Chan, J. G., Sachinidis, J. I., O'Keefe, G., Pathmaraj, K., Wesnes, K. A., et al. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.05.006 · Cited by 57
Giribaldi, J., & Dutertre, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.063 · Cited by 57
Binding of native κ-neurotoxins and site-directed mutants to nicotinic acetylcholine receptors
Chiappinelli, V. A., Weaver, W. R., McLane, K. E., Conti‐Fine, B. M., Fiordalisi, J. J., & Grant, G. A. (1996) · Toxicon · doi:10.1016/s0041-0101(96)00110-9 · Cited by 57
Tohgi, H., Utsugisawa, K., Yoshimura, M., Nagane, Y., & Mihara, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00205-5 · Cited by 57
Figl, A., Viseshakul, N., Shafaee, N., Forsayeth, J., & Cohen, B. N. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.655ba.x · Cited by 55
Tizabi, Y., Louis, V. A., Taylor, C. T., Waxman, D., Culver, K. E., & Szechtman, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01207-0 · Cited by 56
Nicotine cue: lack of effect of the α7 nicotinic receptor antagonist methyllycaconitine
Brioni, J. D., Kim, D. J. B., & O'Neill, A. B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00010-6 · Cited by 56
López‐Hernández, G. Y., Sánchez-Padilla, J., Ortiz‐Acevedo, A., Lizardi-Ortiz, J. E., Salas-Vincenty, J., Rojas, L. V., & Lasalde‐Dominicci, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403537200 · Cited by 56
Clarke, P. B. S., Reuben, M., & El-Bizri, H. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14793.x · Cited by 57
Kulak, J. M., McIntosh, J. M., & Quik, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.230 · Cited by 56
The promise and pitfalls of a nicotinic cholinergic approach to pain management
Flores, C. M. (2000) · Pain · doi:10.1016/s0304-3959(00)00389-4 · Cited by 56
Nicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy-Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12251 · Cited by 58
Whiteaker, P., Cooper, J. F., Salminen, O., Marks, M. J., McClure‐Begley, T. D., Brown, R. W. B., Collins, A. C., & Lindstrom, J. M. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21181 · Cited by 56
Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.076 · Cited by 55
The role of nicotinic receptor α7 subunits in nicotine discrimination
Stolerman, I. P., Chamberlain, S. A. F., Bizarro, L., Fernandes, C., & Schalkwyk, L. C. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.002 · Cited by 56
Activation and inhibition of rat neuronal nicotinic receptors by ABT‐418
Papke, R. L., Thinschmidt, J. S., Moulton, B., Meyer, E. M., & Poirier, A. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700930 · Cited by 55
Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist
Sacaan, A. I., Reid, R. T., Santori, E. M., Adams, P., Correa, L. D., Mahaffy, L. S., Bleicher, L. S., Cosford, N. D. P., Stauderman, K. A., McDonald, I. A., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36402-x · Cited by 55
Multiple Pharmacophores for the Selective Activation of Nicotinic α7-Type Acetylcholine Receptors
Horenstein, N. A., Leonik, F. M., & Papke, R. L. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048892 · Cited by 54
Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 57
Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
Mamede, M. H., Ishizu, K., Ueda, M., Mukai, T., Iida, Y., Fukuyama, H., Saga, T., & Saji, H. (2004) · PubMed · Cited by 54
Ethanol modulates nicotine-induced upregulation of nAChRs
Dohrman, D. P., & Reiter, C. K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02593-9 · Cited by 54
Marks, M. J., Whiteaker, P., & Collins, A. C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025338 · Cited by 53
The nicotinic cholinergic system function in the human brain
Nees, F. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.021 · Cited by 57
Eriksson, P., Ankarberg, E. H., Viberg, H., & Fredriksson, A. (2001) · Neurotoxicity Research · doi:10.1007/bf03033229 · Cited by 53
Kulak, J. M., Sum, J., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00868.x · Cited by 53
Pharmacological and null mutation approaches reveal nicotinic receptor diversity
Whiteaker, P., Marks, M. J., Grady, S. R., Lü, Y., Picciotto, M. R., Changeux, J., & Collins, A. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00052-2 · Cited by 51
Stauderman, K. A., Mahaffy, L. S., AKONG, M., Veliçelebi, G., Chavez-Noriega, L. E., Crona, J. H., Johnson, E. C., Elliott, K. J., Gillespie, A. J., Reid, R. T., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37270-2 · Cited by 90
Yeh, J. J., Yasuda, R. P., Dávila‐García, M. I., Xiao, Y., Ebert, S. N., Gupta, T., Kellar, K. J., & Wolfe, B. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00259.x · Cited by 52
Cholinergic drugs potentiate human nicotinic α4β2 acetylcholine receptors by a competitive mechanism
Smulders, C., Zwart, R., Bermúdez, I., van Kleef, R. G. D. M., Groot‐Kormelink, P. J., & Vijverberg, H. P. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.037 · Cited by 52
Renó, L. A. C., Zago, W. M., & Markus, R. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.023 · Cited by 52
Huang, L. Z., & Winzer‐Serhan, U. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.084 · Cited by 52
Greenwood, P. M., Lin, M., Sundararajan, R., Fryxell, K. J., & Parasuraman, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807891106 · Cited by 51
Defining Nicotinic Agonist Binding Surfaces through Photoaffinity Labeling
Tomizawa, M., Maltby, D. A., Medzihradszky, K. F., Zhang, N., Durkin, K. A., Presley, J. M., Talley, T. T., Taylor, P., Burlingame, A. L., & Casida, J. E. (2007) · Biochemistry · doi:10.1021/bi700667v · Cited by 51
Vibat, C. R. T., Lasalde, J. A., McNamee, M. G., & Ochoa, E. L. M. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071877 · Cited by 51
Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats
Boyce, S., Webb, J. K., Shepheard, S. L., Russell, M. G. N., Hill, R., & Rupniak, N. M. J. (2000) · Pain · doi:10.1016/s0304-3959(99)00303-6 · Cited by 50
Nicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes
Marritt, A. M., Cox, B. C., Yasuda, R. P., McIntosh, J. M., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012369 · Cited by 50
Alkondon, M., & Albuquerque, E. X. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081232 · Cited by 51
Mansbach, R. S., Chambers, L. K., & Rovetti, C. C. (2000) · Psychopharmacology · doi:10.1007/s002130050047 · Cited by 50
Didier, M., Berman, S. A., Lindstrom, J. M., & Bursztajn, S. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00266-h · Cited by 50
Wilkins, L. H., Haubner, A. J., Ayers, J. T., Crooks, P. A., & Dwoskin, L. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1088 · Cited by 50
Neuronal Nicotinic Acetylcholine Receptors
Lukas, R. J. (1998) · Springer eBooks · doi:10.1007/978-3-662-40279-5_7 · Cited by 50
Associative Learning, the Hippocampus, and Nicotine Addiction
Gould, T. J., & Davis, J. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801010009 · Cited by 49
Poorthuis, R. B., & Mansvelder, H. D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.003 · Cited by 54
Moulédous, L., Topham, C. M., Moisand, C., Mollereau, C., & Meunier, J. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.3.495 · Cited by 49
Slotkin, T. A., Southard, M. C., Adam, S. J., Cousins, M. M., & Seidler, F. J. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.07.005 · Cited by 47
Nicotine and Behavioral Sensitization
Mao, D., & McGehee, D. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9230-7 · Cited by 50
Gahring, L. C., Meyer, E. L., & Rogers, S. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02074.x · Cited by 48
Analgesic effects of sazetidine-A, a new nicotinic cholinergic drug
Cucchiaro, G., Xiao, Y., Gonzalez-Sulser, A., & Kellar, K. J. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181834490 · Cited by 47
Self-citationPandya, A. A., & Yakel, J. L. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9509-3 · Cited by 47
Rapid Effect of Nicotine Intake on Neuroplasticity in Non-Smoking Humans
Grundey, J., Thirugnanasambandam, N., Kaminsky, K., Drees, A., Skwirba, A. C., Lang, N., Paulus, W., & Nitsche, M. A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00186 · Cited by 52
Miwa, J. M., Anderson, K., & Hoffman, K. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00343 · Cited by 46
Gentry, C. L., Wilkins, L. H., & Lukas, R. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041756 · Cited by 47
Singh, S., Singh, K., Patel, D. K., Singh, C., Nath, C., Singh, V. K., Singh, R. K., & Singh, M. P. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0850 · Cited by 47
Protective effects of nicotine on ethanol-induced toxicity in cultured cerebellar granule cells
Tizabi, Y., Al-Namaeh, M., Manaye, K. F., & Taylor, R. E. (2003) · Neurotoxicity Research · doi:10.1007/bf03033151 · Cited by 47
Ulrich‐Lai, Y. M., Hargreaves, K., & Flores, C. M. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00107-x · Cited by 47
Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus
Bertolino, M., Kellar, K. J., Vicini, S., & Gillis, R. A. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00026-2 · Cited by 46
Shacka, J. J., & Robinson, S. E. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00564-2 · Cited by 46
COURT, J. A., & Perry, E. K. (1994) · CNS Drugs · doi:10.2165/00023210-199402030-00006 · Cited by 46
Nakauchi, S., & Sumikawa, K. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08056.x · Cited by 45
Wu, M., Puddifoot, C. A., Taylor, P., & Joiner, W. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647248 · Cited by 45
Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence
Fowler, C. D., Turner, J. R., & Damaj, M. I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_252 · Cited by 50
Terry, A. V., Williamson, R., Gattu, M., Beach, J. W., McCurdy, C. R., Sparks, J. A., & Pauly, J. R. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(97)00142-1 · Cited by 45
Tobacco use as drug addiction: The scientific foundation
Henningfield, J. E., & Fant, R. V. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011781 · Cited by 45
Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain
Sihver, W., Långström, B., & Nordberg, A. K. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00304.x · Cited by 45
Wilkins, L. H., Grinevich, V. P., Ayers, J. T., Crooks, P. A., & Dwoskin, L. P. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043349 · Cited by 45
Booker, T. K., & Collins, A. C. (1997) · Alcohol · doi:10.1016/s0741-8329(96)00116-4 · Cited by 46
Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors
Pandya, A. A., & Yakel, J. L. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.020 · Cited by 48
Garcia‐Ratés, S., Camarasa, J., Escubedo, E., & Pubill, D. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.015 · Cited by 44
The Role of Nicotine in Schizophrenia
Featherstone, R. E., & Siegel, S. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.002 · Cited by 47
Huang, X., Zheng, F., Crooks, P. A., Dwoskin, L. P., & Zhan, C. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052681+ · Cited by 44
Bitner, R. S., & Nikkel, A. L. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02485-x · Cited by 44
Behavioural Pharmacology and Neurobiology of Nicotine Reward and Dependence
Chiara, G. D. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_24 · Cited by 44
Tanaka, A., & Nishizaki, T. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00089-1 · Cited by 42
Bencherif, M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.37 · Cited by 44
The neuronal nicotinic α4β2 receptor has a high maximal probability of being open
Li, P., & Steinbach, J. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00761.x · Cited by 41
Wei, D., Sirois, S., Du, Q., Arias, H. R., & Chou, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.047 · Cited by 42
Tizabi, Y., Getachew, B., Rezvani, A. H., Hauser, S. R., & Overstreet, D. H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.09.010 · Cited by 42
Spilman, P. R., Descamps, O., Gorostiza, O. F., Peters-Libeu, C. A., Poksay, K. S., Matalis, A., Campagna, J. J., Patent, A., Rao, R. V., John, V., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2013.12.029 · Cited by 44
Marks, M. J., Meinerz, N. M., Drago, J., & Collins, A. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.021 · Cited by 42
The Nicotinic Receptor in the Rat Pineal Gland Is an α3β4 Subtype
Hernandez, S. C., Vicini, S., Xiao, Y., Dávila‐García, M. I., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002345 · Cited by 42
Metadata
- Authors
- Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J.
- Affiliations
- Georgetown University Medical Center (US)
- University of Colorado Denver (US)
- Georgetown University (US)
- ORCID
- Kellar, K J
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 41
- Issue
- 1
- Pages
- 31-37
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2116249462
- Cited by
- 880
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 18 · 2015: 25 · 2014: 25 · 2013: 22 · 2012: 21
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (5r01ag009884-05, 5r01da006486-10, 5r01ns011549-24)
- National Institute on Aging (AG 09884)
- National Institute on Drug Abuse (DA-06486)
- National Institute of Neurological Disorders and Stroke (NS11549)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor subunit composition, chronic nicotine treatment, receptor up-regulation, rat cortex, forebrain, neuronal nicotinic receptors
- MeSH terms
- Quinolizidine Alkaloids, Alkaloids, Animals, Antibodies, Azocines, Brain, Kinetics, Male, Nicotine, Precipitin Tests, Quinolizines, Rats, Inbred Strains, Receptors, Nicotinic, Time Factors, Tritium, Up-Regulation, Macromolecular Substances, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review